Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2017-04-25 | He received a B.A. from Stanford University and an M.B.A. from Northwestern University’s Kellogg Graduate School of Management. |
| 2018-04-25 | Mr. Wilder has served as CEO of several medical device companies and began his career in financial statement audit practice; he holds a B.A. from Stanford University and an M.B.A. from Northwestern University’s Kellogg Graduate School of Management. |
| 2019-04-26 | Mr. Wilder has served as the Chief Executive Officer of Neuros Medical, Inc., a neuro-modulation company. He also served as CEO of other medical device companies and worked in financial statement audit practice. |
| 2020-04-23 | He received a B.A. from Stanford University and an M.B.A. from Northwestern University’s Kellogg Graduate School of Management. |
| 2021-04-22 | He received a B.A. from Stanford University and an M.B.A. from Northwestern University’s Kellogg Graduate School of Management. |
| 2022-04-20 | Mr. Wilder has served as the President and Chief Executive Officer of Neuros Medical, Inc., a neuro-modulation company. From February 2010 through July 2016, Mr. Wilder served as the Chief Executive Officer of Sequent Medical, Inc., a company dedicated to the development of innovative catheter-based neurovascular technologies. |
| 2023-04-19 | Mr. Wilder received a B.A. from Stanford University and an M.B.A. from Northwestern University’s Kellogg Graduate School of Management. |
| 2024-04-24 | Mr. Wilder served as CEO of several medical device companies and began his career in financial statement audit. He holds a B.A. from Stanford University and an M.B.A. from Northwestern University. |
Data sourced from SEC filings. Last updated: 2026-03-05